Most Recent
Special leave refused in dispute over $81.8M Parklea Markets sale
The High Court has refused Sydney retail personality Con Constantine’s bid to challenge a $4.25 million judgment in his favour over the $81.8 million Parklea Markets sale in 2016.
Mills Oakley nabs litigation partner from Thomson Geer
Mills Oakley has picked up a leading dispute resolution lawyer from Thomson Geer to join the firm’s not-for-profit team as partner.
Opal Tower class action reaches eleventh-hour settlement before 40-day trial
A long-running class action over the Opal Tower disaster has settled, along with two related cases over the defective building, as a five-week trial was set to begin.
Shine Lawyers wins battle to run $463M Dixon Advisory class action
Shine Lawyers has beaten out class action rival Piper Alderman in a battle to lead a class action worth up to $463 million against collapsed wealth managers Dixon Advisory, with a judge finding the firm's no win, no fee model was likely to result in a greater return to group members.
Law firm’s tiered contingency fee in doubt in Beach Energy class actions
A judge deciding one of the first ever applications by a law firm for a percentage cut of a class action will have to determine whether Victoria's ground-breaking contingency fee legislation allows a group costs order to operate with a sliding percentage return.
Quintis class action settlement takes hit as insurers win appeal
Two insurers have won an appeal that blocks group members in a class action against sandalwood producer Quintis from receiving a further $11.25 million after a settlement was reached almost two years ago. 
Mesoblast hit with shareholder class action over stem cell treatment
Regenerative medicine company Mesoblast is facing another class action over claims it misled shareholders about the potential application of a developmental stem cell product to treat terminally ill children.
Full Court shoots down Boehringer opposition to Merck Sharp & Dohme’s parasite patent
The Full Federal Court has rejected German drug maker Boehringer Ingelheim's appeal of ruling that shot down its opposition to Merck Sharp & Dohme's patent application for an injectable anti-parasite drug for livestock.
Andrews government tries again to strike out hotel quarantine class action
The state of Victoria has asked a court to strike out a class action alleging lapses in its hotel quarantine program caused businesses to suffer losses when stage three and four COVID-19 restrictions were put in place between July and August 2020.
High Court asked to decide if AI can be inventor on patent
The High Court has been asked to wade into the debate over whether artificial intelligence can be named as an inventor on patent applications, after the Full Court overturned a landmark victory for AI pioneer Dr Stephen Thaler.